Hirata, A.S.; La Clair, J.J.; Jimenez, P.C.; Costa-Lotufo, L.V.; Fenical, W.
Preclinical Development of Seriniquinones as Selective Dermcidin Modulators for the Treatment of Melanoma. Mar. Drugs 2022, 20, 301.
https://doi.org/10.3390/md20050301
AMA Style
Hirata AS, La Clair JJ, Jimenez PC, Costa-Lotufo LV, Fenical W.
Preclinical Development of Seriniquinones as Selective Dermcidin Modulators for the Treatment of Melanoma. Marine Drugs. 2022; 20(5):301.
https://doi.org/10.3390/md20050301
Chicago/Turabian Style
Hirata, Amanda S., James J. La Clair, Paula C. Jimenez, Leticia Veras Costa-Lotufo, and William Fenical.
2022. "Preclinical Development of Seriniquinones as Selective Dermcidin Modulators for the Treatment of Melanoma" Marine Drugs 20, no. 5: 301.
https://doi.org/10.3390/md20050301
APA Style
Hirata, A. S., La Clair, J. J., Jimenez, P. C., Costa-Lotufo, L. V., & Fenical, W.
(2022). Preclinical Development of Seriniquinones as Selective Dermcidin Modulators for the Treatment of Melanoma. Marine Drugs, 20(5), 301.
https://doi.org/10.3390/md20050301